Gene Discovery News: Breaking Gene Discovery News, Comments and Articles. - Page: 5

21:04 EDT 31st October 2014 | BioPortfolio

Gene Discovery News - Page: 5RSS

Read the latest Gene Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Gene Discovery.

Search or Follow Our Gene Discovery - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Gene Discovery - Page: 5 News.

Showing "gene discovery" News Articles 101 to 125 of 7,400+

Wednesday 29th October 2014

Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents & Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes & Probes, Radiopharmaceuticals & Quantum Dots) - Global Industry Analysis, Size, Share,

LONDON, Oct. 29, 2014 /PRNewswire/ -- A surge in the number of cancer and cardiovascular patients globally has prompted the growth of the medical imaging reagents market. Medical imaging reagents play a significant role in diagnostic, pharmaceuticals, biotechnology medical and life science industries. These reagents allow clinicians and healthcare providers to determine whether a tumor is malignan...

Mount Sinai Researchers Find that Changes in Scores of Genes Contribute to Autism Risk

Newfound Genetic Differences Provide Many Hints at Causes New York, NY (PRWEB) October 29, 2014 Small differences in as many as a thousand genes contribute to risk for autism, according to a study led by Mount Sinai researchers and the Autism Sequencing Consortium (ASC), and published today in the journal Nature. The new study examined data on several types of rare, genetic differences in more t...

Life Science Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

LONDON, Oct. 29, 2014 /PRNewswire/ -- This report covers the market analysis for various reagents used in the life science industry. Continuous innovation in biotechnology is driving the life science reagents market towards remarkable growth. The stakeholders for this study include manufacturers and providers of life science reagents. The global life science reagents market is categorized on the b...

Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

LONDON, Oct. 29, 2014 /PRNewswire/ -- Transfection is a technique used to introduce nucleic acids (either DNA or RNA) into cells. This technology helps the cells to regulate gene therapy, mutation of cancer cells and protein metabolism by affecting the nuclear genes. The transfection technology market is driven by factors such as increasing demand for protein production, emerging biopharmaceutical...

Discovery of 100-Plus Genes Tied to Autism May Improve Treatments

WEDNESDAY, Oct. 29, 2014 -- More than 100 genes have been identified that appear linked to autism spectrum disorders, two new studies report. And researchers say they are on their way to discovering up to 1,000 genes overall that may contribute to...

Molecular Devices and Roche form a biotech partnership for Nano-TRF assay

Molecular Devices has partnered with the Discovery Technologies team at the Roche announced a biotech partnership to develop a high-throughput detection system for drug discovery screens employing Roche’s proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF) assays. The pRED screening teams in Basel and Shanghai are now installing the custom-developed Nano-TRF cartridg...

UCB calls upon UK government for greater incentives for industry partnering

Belgian drugmaker UCB has called for further collaboration in life sciences to enhance drug discovery and help drive economic growth at its networking event at the Royal College of Surgeons for PhD scientists.

Scientists Generate First Human Stomach Tissue in Lab with Stem Cells

CINCINNATI, Oct. 29, 2014 /PRNewswire-USNewswire/ -- Scientists used pluripotent stem cells to generate functional, three-dimensional human stomach tissue in a laboratory – creating an unprecedented tool for researching the development and diseases of an organ central to several public health crises, ranging from cancer to diabetes. Scientists at Cincinnati Children's Hospital Medical Cent...

JH Technologies Hosts North California Society for Microscopy Meeting

Professor Isaacson, of UC Santa Cruz, presents a brief history of the utilization of microscopic tools for exploring inner space at the atomic and nanoscale dimensions Fremont, CA (PRWEB) October 29, 2014 JH Technologies hosted the Northern California Society for Microscopy meeting in it’s training center located in Fremont California. The Microscopy Society of America (MSA) is a non-profit org...

DynaMed™ Adds 61 Recently Released Choosing Wisely Canada Recommendations

Recommendations from 12 Organizations are now Easily Accessible to Healthcare Providers at the Point-of-Care IPSWICH, Mass. (PRWEB) October 29, 2014 Choosing Wisely Canada just released 61 recommendations that are now available in the evidence-based clinical support tool DynaMed™ from EBSCO Health. The new recommendations to avoid unnecessary tests and treatments are from 12 organizati

Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014

BOULDER, Colo., Oct. 29, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, November 4, 2014.  Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call. Date:   Tuesday, November 4, 2014

In autoimmune diseases affecting millions, researchers pinpoint genetic risks, cellular culprits

Scores of autoimmune diseases afflicting one in 12 Americans -- ranging from type 1 diabetes, to multiple sclerosis (MS), to rheumatoid arthritis, to asthma -- mysteriously cause the immune system to harm tissues within our own bodies. Now, a new stu...

New way of genome editing cures hemophilia in mice; may be safer than older method

The ability to pop a working copy of a faulty gene into a patient's genome is a tantalizing goal for many clinicians treating genetic diseases. Now, researchers at the Stanford University School of Medicine have devised a new way to carry out this ge...

In autoimmune diseases, researchers pinpoint genetic risks, cellular culprits

Scores of autoimmune diseases afflicting one in 12 Americans—ranging from type 1 diabetes, to multiple sclerosis (MS), to rheumatoid arthritis, to asthma—mysteriously cause the immune system to harm tissues within our own bodies. Now, a new study...

Receptos rockets on positive mid-stage results for UC drug candidate

US discovery and development company Receptos saw its shares rocket 47% to a new high, after it announced that TOUCHSTONE, the Phase II trial of RPC1063 in ulcerative colitis (UC), met its primary endpoint .

Renaissance RX Announces New Chief Financial Officer Thierry Amat

NEW ORLEANS, Oct. 29, 2014 /PRNewswire/ -- Thierry Amat joined Renaissance RX this month as its executive vice president and chief financial officer (CFO). With experience in mergers and acquisitions and more than 20 years in pharmaceuticals, Amat will be a valuable asset to the fast-growing company. Renaissance RX began in 2012 with five employees and today employs more than 800 team membe...

Alnylam Appoints Pushkal Garg, M.D., Senior Vice President, Clinical Development

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the appointment of Pushkal Garg, M.D., to the position of Senior Vice President, Clinical Development. Dr. Garg has extensive experience in clinical development across a broad range of therapeutic areas. At Alnylam, he will join the existing development ...

Mechanism that allows differentiated cell to reactivate as a stem cell revealed

A study, performed with fruit flies, describes a gene that determines whether a specialized cell conserves the capacity to become a stem cell again. Unveiling the genetic traits that favor the retention of stem cell properties is crucial for regenera...

Acceleron Pharma to Present at Upcoming Investor Conferences in November

Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will participate in several upcoming investor conferences.   Event: ...

Compugen Ltd. Reports Third Quarter 2014 Financial Results

Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the third quarter and nine months ending September 30, 2014. Dr. Anat Cohen-Dayag, Compugen’s President and CEO, stated, "During 2014 we were pleased to report continuing progress with respect to our early stage B7/CD28-like checkpoint based immuno-oncology programs. These ...

10.28.14 -- Experts To Advance Drug Discovery For Neurodegenerative Diseases; SDV In Risk-Based Monitoring Misunderstood?

10/28/14 Pharmaceutical Online Newsletter

Synta Announces Initiation of I-SPY 2 TRIAL of Ganetespib in Breast Cancer

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) today announced the initiation of the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) arm evaluating ganetespib, the Company’s Hsp90 inhibitor, as a neoadjuvant therapy for patients with breast cancer. I-SPY 2 is a standing Phase 2 randomi...

StratAcuity Proud to Complete the Proteostasis Therapeutics Cystic Fibrosis Inaugural Clinical Advisory Board Search

StratAcuity, The Science of People: StratAcuity successfully completes the search for the Proteostasis Therapeutics Inaugural Cystic Fibrosis Clinical Advisory Board. Boston, MA (PRWEB) October 29, 2014 StratAcuity successfully completes the search for the Proteostasis Therapeutics Inaugural Cystic Fibrosis Clinical Advisory Board. The newly appointed board will serve as a strategic resource for t...

Molecular Devices and Roche partner to develop detection platform for drug discovery screens

Bioanalytical measurement systems supplier Molecular Devices has partnered with Roche to develop Custom Ruthenium Nano-TRF Detection Platform.

The Galien Foundation Honors Excellence in Scientific Innovation and Humanitarian Efforts at 2014 Prix Galien Awards Gala

NEW YORK, Oct. 29, 2014 /PRNewswire/ -- The Prix Galien USA committee last night honored excellence in research, development and innovation in the biopharmaceutical and medical industry at its eighth annual Prix Galien Awards Gala, held at the American Museum of Natural History in New York City. The Galien awards committee recognized leading efforts in progressing the welfare of humankind in ...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks